|Vivus Inc||(NQ: VVUS)|
2.850 USD +0.040 (+1.42%)
Official Closing Price / Updated: 4:00 PM EST, Dec 17, 2018 / Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
VIVUS Reports Third Quarter 2018 Financial Results
November 01, 2018
VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with... Read More
VIVUS Adds Two New Members to the Board of Directors
October 29, 2018
VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced that Karen Ferrell and Edward A. Kangas have been appointed to VIVUS’ board of directors. With these... Read More
System response times may vary due to a variety of factors, including trading volumes, market conditions, and system performance.
© 1st Discount Brokerage, Inc. All rights reserved. Member FINRA and SIPC. Registered Investment Adviser.
As a member of the Securities Investor Protection Corporation (SIPC), funds are available to meet customer claims up to a ceiling of $500,000, including a maximum of
$250,000 for cash claims. For additional information regarding SIPC coverage, including a brochure, please contact SIPC at (202) 371-8300 or visit www.sipc.org
Our clearing firm, Apex Clearing Corporation, has purchased an additional insurance policy through a group of London Underwriters (with Lloyd's of London Syndicates as the Lead Underwriter) to supplement SIPC protection. This additional insurance policy becomes available to customers in the event that SIPC limits are exhausted and provides protection for securities and cash up to an aggregate of $150 million. This is provided to pay amounts in addition to those returned in a SIPC liquidation. This additional insurance policy is limited to a combined return to any one customer of $37.5 million for securities and $900,000 for cash. Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities.